By: Ames Gross and Catherine Matacic
February 18, 2013
Published by Pacific Bridge Medical
Vietnam's 2012 GDP growth rate was about 5 percent, down from 7 percent in 2010. But its economy is still very strong compared to the West, where growth rates have ranged from 0 to 2 percent. Vietnam's medical device market is expanding rapidly. The market -- valued at $634 million in 2012 -- is expected to grow 18 to 20 percent from now through 2017.
By: Ames Gross
February 1, 2012
Published by Pacific Bridge Medical
With a population of close to 90 million, Vietnam has one of the least-developed pharmaceutical markets in Asia, with relatively low per capita spending on drugs. However, there is significant growth potential in the country. While Vietnam's healthcare industry is still developing, it is one of the faster growing markets in the global healthcare industry. It is expected that Vietnam's pharmaceutical market will continue its strong growth of about 20% a year. It is very likely the drug market will surpass $2 billion in 2012. These growth factors will attract foreign investors to invest in the pharmaceutical market in Vietnam.
Webcast by Pacific Bridge Medical
Pacific Bridge Medical presents Updates on Vietnam's Medical Device Market, a 2011 webcast/webinar on recent regulatory issues for medical devices in Vietnam.
By: Ames Gross and John Minot
May 1, 2009
Published in MD&DI
Vietnam is currently attracting a great deal of foreign investment, especially from foreign medical device manufacturers that are relocating due to rising wages in coastal and southern China. American and European medical device makers dominate the market, but more and more global medical device manufacturers are considering the country as a location for manufacturing-- not just selling-- their products. For other manufacturers eyeing the market, this article describes the major regulatory requirements.
By: Ames Gross and John Minot
February 1, 2009
Published in MPO
Navigating global regulatory markets can be a challenge, particularly when multiple countries in a region differ in their rules. Playing by a common set of rules for medtech regulation is about to get a little easier in Southeast Asia, as a group of countries prepares to unveil a more unified approach to oversight.
Webcast by Pacific Bridge Medical
Pacific Bridge Medical presents Managing Asian Cultural/Business Diversity, a 2008 webcast/webinar on cross-cultural issues for Western companies doing business in Asia.
Webcast by Pacific Bridge Medical
Pacific Bridge Medical presents ASEAN Medical Device Harmonization Trends, a webcast/webinar on the medical device regulatory environment in the Southeast Asian nations, including Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam.
By: Ames Gross and John Minot
November 1, 2007
Published in RA Focus
This report helps medical device manufacturers and distributors better understand how to source from Asia. Topics covered include: how to identify manufacturers, how to perform due diligence, what to look for during factory visits, contract negotiations, regulatory requirements, logistics, quality control, and other issues related to the sourcing equation. This report will also offer advice on how to avoid and troubleshoot problems and pitfalls that may arise in the course of the sourcing process, as well as information about insurance, payment arrangements, freight forwarding, and customs.
Furthermore, we will include Microsoft Excel spreadsheet templates on CD-ROM with this report that will facilitate your transportation and shipping decisions when dealing with multiple SKUs being shipped in one container.
September 14, 2006
$400 Buy CDWebcast by Pacific Bridge Medical
Pacific Bridge Medical presents Vietnam's Medical Markets, a 2006 webcast/webinar that includes information on regulations and issues for both medical devices and drugs/pharmaceuticals in Vietnam.
By: Ames Gross
October 1, 2005
Presented at the Orange County Regulatory Affairs Discussion Group
Pharmaceutical and medical device markets are expanding throughout Asia. This presentation covers the medical device and pharmaceutical markets in Taiwan, Hong Kong, Malaysia, Singapore, India and Vietnam, and provides country-specific information about drug, device and IVD regulations in these countries. Specific topics include registration, pricing and reimbursement, manufacturing and GMP, import licenses, patents, and clinical trials in these countries.
By: Ames Gross and Rachel Weintraub
July 1, 2005
Published by Pacific Bridge Medical
Vietnam ’s population totals around 84 million and its economy boasted a 7.7 percent GDP growth rate in 2004. While Vietnam’s healthcare industry is still developing, it is one of the faster growing markets in the global healthcare industry. In 2003, Vietnam spent nearly $420 million on pharmaceutical imports, ten times the amount spent in 1993. Presently, more than 200 foreign pharmaceutical companies are registered in Vietnam, making up 90 percent of the country’s market share. Likewise, the medical device industry in Vietnam is also comprised mostly of foreign imports, with the U.S. holding close to 40 percent of the market; other countries with a large presence in the market include Japan and Germany. Vietnam’s medical device market, currently worth over $185 million, has been growing steadily at around 10 percent annually for the past several years.
By: Ames Gross
January 1, 2000
Published by Pacific Bridge Medical
This article explains some of the basic features of Vietnam’s healthcare system and how its imported pharmaceuticals and medical equipment market is growing. While Vietnam’s healthcare system is centralized, the Ministry of Health (MoH) is eager to improve healthcare facilities and healthcare for the people. Vietnam did not have formal drug policy regulations until 1996; since then, new laws and regulations have been implemented to help control price, license registration, distribution, and patent and trademark protection. The government is making an effort to introduce such standards as the “Good Manufacturing Practice” (GMP), among others, to meet ASEAN pharmaceutical guidelines. Vietnam’s medical market holds future promise as long as the government continues to implement more standard practices and reforms for its healthcare system.
By: Ames Gross
December 1, 1999
Published by Pacific Bridge Medical
This article is a review of Vietnam’s small, but expanding pharmaceutical market. Growing demand and weak domestic production are encouraging foreign companies to sell and distribute their drugs and pharmaceuticals in Vietnam. Foreign companies can be successful in Vietnam if they study the market, seek the proper distributors and maintain contact with the key ministries in Vietnam including, the Ministry of Public Health, the Ministry of Trade, and the Ministry of Planning and Investment.
By: Ames Gross and Gayatri B. Koolwal
July 1, 1998
Published in Medical Device & Diagnostic Industry Magazine
Despite its currency crisis, Asia still offers manufacturers many opportunities.
Asia's recent currency crisis has caused some U.S. medical device companies to wonder whether there is still a market for their products and services. Concern has risen that Asians have lost their purchasing power, meaning a decrease in U.S. exports to Asia and an unstable economic environment in which to invest. However, not all manufacturers have fled the region. Several companies feel that the crisis has opened new opportunities for manufacturing in Southeast Asia.
By: Ames Gross
December 5, 1994
Published in Clinica, a publication of PJB Publications, Ltd.
Southeast Asia’s economic prosperity has encouraged governments to focus on revamping their healthcare systems. The healthcare sector in Vietnam has seen an expanded growth rate in recent times, and the government is eager to reform its medical insurance system and import more sophisticated equipment to bolster its reform efforts. Previously, Vietnam’s medical device market has been dominated by Japanese, German and French suppliers, but U.S. medical equipment companies and suppliers are slowly appearing. This article discusses the future prospects of the Vietnamese medical market. As long as political and economic reforms continue in Vietnam, the future will be bright for foreign suppliers.
By: Ames Gross
January 1, 1992
Published by Pacific Bridge Medical
A basic guide to conducting business in China, Japan and Southeast Asia. Topics include personal and business relationships, negotiating, gift-giving, body language, introductions and language and cultural differences.
Back to Top
